Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-07

Clinical Trial Update: A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis [Phase 2]

View source ↗

Summary

An update on a Phase 2 pilot study evaluating sirolimus as a treatment for systemic sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Systemic Sclerosis | Phase 2 | Status: UNKNOWN